Integrin Trafficking and Tumor Progression by Shin, Sejeong et al.
Hindawi Publishing Corporation
International Journal of Cell Biology
Volume 2012, Article ID 516789, 7 pages
doi:10.1155/2012/516789
Review Article
Integrin Trafﬁckingand Tumor Progression
Sejeong Shin,LauraWolgamott, andSang-OhYoon
Department of Cancer and Cell Biology, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
Correspondence should be addressed to Sang-Oh Yoon, yoonsh@ucmail.uc.edu
Received 27 July 2011; Accepted 12 September 2011
Academic Editor: Jun Chung
Copyright © 2012 Sejeong Shin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Integrins are major mediators of cancer cell adhesion to extracellular matrix. Through this interaction, integrins play critical
roles in cell migration, invasion, metastasis, and resistance to apoptosis during tumor progression. Recent studies highlight
the importance of integrin traﬃcking, endocytosis and recycling, for the functions of integrins in cancer cells. Understanding
the molecular mechanisms of integrin traﬃcking is pivotal for understanding tumor progression and for the development of
anticancer drugs.
1. Integrinsand Cancer
Most of the cells in multicellular organisms are surrounded
by a complex mixture of nonliving materials that make up
the extracellular matrix (ECM). The ECM of vertebrates
is composed of complex mixtures of proteins (collagens,
laminins, ﬁbronectin, etc.) and proteoglycans (chondroitin
sulfate, keratan sulfate, etc.) [1, 2]. ECM plays a signiﬁcant
role in regulating numerous cellular functions, including cell
shape, adhesion, migration, proliferation, polarity, diﬀeren-
tiation, and apoptosis [1]. In pathological conditions such
as cancer, increased synthesis of certain ECM components
and/or increased breakdown with consequent generation of
ECM cleavage products can contribute to cancer growth and
progression [3].
Cells attach to the ECM by means of integrins. Integrins
are transmembrane glycoproteins that are composed of a set
of noncovalently associated α and β subunits. There are at
least18αand8β subunitscapableofformingmorethan24αβ
heterodimers that account for the structural and functional
diversity of the integrin family [4–6]. Integrins consist
of a large extracellular domain, a single transmembrane
domain, and a cytoplasmic tail [7]. The extracellular portion
of integrins binds to ECM proteins, and the intracellular
portion binds to cellular cytoskeletal elements such as actin
ﬁlaments. This connection reinforces tissue integrity and cell
adhesion and stabilizes cell protrusions during migration.
Theconnectionalsoconstitutesasignalingplatformthrough
which integrins can relay information for major processes
such as transcriptional control, cell death, proliferation, and
cell migration [8, 9]. There is a growing body of evidence
suggesting that alterations in the adhesion properties of
neoplastic cells endow them with an invasive and migratory
phenotype. Indeed, changes in the expression and/or func-
tion of integrins have been implicated in all steps of tumor
progression, including detachment of tumor cells from the
primary site, invasion of ECM, intravasation into the blood
stream, dissemination through the circulation, extravasation
into distant target organs, and formation of the secondary
lesions [5, 10–13].
Although at least 24αβ integrin heterodimers are known,
α5β1, α6β4, αvβ3, and αvβ6 integrins have been extensively
studied in cancer and their expression is correlated with
cancer progression in various tumor types [14–18]. Upreg-
ulation of these integrins renders cancer cells more motile,
invasive, and resistant to anticancer drugs [5, 18]. Unlike
these integrins, expression levels of some integrins, such as
α2β1a n dα1β1, decrease in tumor cells, which potentially
increase tumor cell dissemination [18–21]. In addition to
changes in expression, changes in the function of these
integrins also play a critical role in cancer progression.
2. IntegrinTrafﬁcking
The way in which integrins are traﬃcked by the endosomal
pathwayisnowrecognizedtoinﬂuencetheirfunction[6,22].
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from the plasma membrane into endosomal compartments
and subsequently recycled back to the cell surface, which
indicates that the endocytic and recycling pathways have
the potential to exert minute-to-minute control over inte-
grin function. Abundant evidence suggests that integrin
traﬃcking regulates cell adhesion to ECM, establishes
and maintains cell polarity, redeﬁnes signaling pathways,
and controls migration [6, 23]. Therefore, transcriptional
changes, mutational alterations, and deregulated cellular
signaling changing endocytosis and recycling of integrins
confer invasive and metastatic properties to tumor cells.
Integrin traﬃcking is regulated by members of the Ras-
associated binding (Rab) family of small GTPases, which
function as molecular switches regulating vesicular transport
in eukaryotic cells [24, 25]( Figure 1). Through their indirect
interactions with coat components, motors, and other
proteins, the Rab GTPases serve as multifaceted organizers
of almost all membrane traﬃcking processes including
integrin traﬃcking [25, 26]. Approximately 70 types of
Rab GTPases have now been identiﬁed in humans [27].
Among these, several Rab GTPases regulate endocytosis and
recycling of integrins. For example, Rab21 mediates integrin
endocytosis (Figure 1). In addition, Rab11 mediates slow
integrin recycling through recycling endosomes, whereas
Rab4 mediates fast integrin recycling directly from early
endosomes (Figure 1)[ 25].
The pathophysiological roles of Rab GTPases in human
malignancieshavebeenlessstudiedcomparedtomembersof
the Ras and Rho GTPase families. However, more attention
has been paid to the roles of Rab GTPases in cancer in recent
years, and several members of the Rab family such as Rab11
and Rab25 have been shown to be aberrantly expressed in
various cancer types [25, 28, 29]. Because of the important
roles of Rab GTPases in integrin traﬃcking, deregulation of
Rab GTPases is closely related to cancer development and
progression [24, 25, 29].
2.1. Integrin Endocytosis. There are several major endocy-
tosis mechanisms, including clathrin-mediated endocytosis,
caveolae-mediated endocytosis, and clathrin- and caveolin-
independent endocytosis [30–33]. Clathrin-mediated endo-
cytosis is mediated by small vesicles that have a mor-
phologically characteristic crystalline coat made up of a
complex of proteins associated with the cytosolic protein
clathrin [33]. Clathrin-coated vesicles (CCVs) are found
in virtually all cells and form domains of the plasma
membrane termed clathrin-coated pits. Clathrin-coated pits
can concentrate large extracellular molecules and receptors
responsible forthe receptor-mediated endocytosis ofligands,
for example, low-density lipoprotein, transferrin, growth
factors, and antibodies [30, 33]. In contrast, caveolae-
mediated endocytosis is mediated by small ﬂask-shape pits,
caveolae, in the membrane. Caveolae are the most common
reported non-clathrin-coated plasma membrane buds which
exist on the surface of many, but not all cell types [33]. They
consist of the cholesterol-binding protein caveolin (Vip21)
with a bilayer enriched in cholesterol and glycolipids [30].
Clathrin- and caveolin-independent endocytosis includes
macropinocytosis and circular dorsal ruﬄes [9, 30, 33].
Clathrin-dependent endocytosis and caveolin-dependent
endocytosis require dynamin and exhibit small vesicles.
However, macropinocytosis does not require dynamin and
displays highly ruﬄed structures. Like macropinocytosis,
circular dorsal ruﬄes show highly ruﬄed structures, but this
endocytosis is dependent on dynamin.
Integrins are known to be endocytosed by clathrin-
mediated endocytosis, caveolae-mediated endocytosis, and
clathrin- and caveolin-independent endocytosis (Table 1). It
is probable that a given type of integrin heterodimer follows
more than one route to internalization depending on regions
within a cell, cell conditions, and cell type [6, 34]. For
instance, a subpopulation of integrin α5β1 is internalized
into clathrin-coated structures near focal complexes at the
cell front, whereas the bulk of integrin α5β1 follows a
nonclathrinpathwayfromotherpartsofthecellsurface[34].
Deregulation of integrin endocytosis is closely related to
cancer development and progression [9, 30]. For example,
chromosomal deletion and loss of Rab21, a regulator of
endocytic traﬃcking of integrins, has been found in cancer
that leads to the accumulation of multinucleate cells in
cancer. The correlation with multinucleate cells is thought
to reﬂect the requirement of Rab21-mediated integrin endo-
cytosis for correct cytokinesis [35]. Rab21 also enhances
cancer cell adhesion and migration by regulating integrin
endocytosis [36].
2.2. Integrin Recycling. Once internalized, integrins are pre-
dominantlyrecycledbacktotheplasmamembrane,although
a fraction of integrin α5β1 has been shown to traﬃct ol y s o -
somes for degradation during migration [6, 37]. Following
endocytosis, integrins travel to early endosomes from which
they can either be returned directly to the plasma membrane
in a Rab4-dependent manner (the short loop) or further
traﬃcked to the perinuclear recycling compartment (PNRC)
before recycling through Rab11-dependent mechanisms (the
long loop) (Table 1). Rab11 GTPase functions have been
linked to tumorigenesis and tumor progression. Rab11 is
upregulated during skin carcinogenesis [38] and is linked to
Barrett’s dysplasia [39]. However, the function of the Rab11
family member Rab25 (or Rab11C) is controversial. Rab25
shows highly restricted expression under normal physiologi-
cal conditions but is upregulated in invasive cancer cell lines
and metastatic tumor cells [40], and its elevated expression
is further linked to the aggressiveness of breast and ovarian
cancers [28]. Rab25 is a determinant of tumor progression,
and the aggressiveness of epithelial cancers and is strongly
associated with decreased survival [28]. In contrast, recent
studies showed that Rab25 expression is decreased in human
colon cancers and triple-negative (negative for estrogen
receptor (ER), progesterone receptor (PR), and Her2/Neu)
breast cancers, and Rab25 functions as a tumor suppressor
in these cancers [41–43]. The key roles of Rab GTPases in
tumorigenesis and tumor progression are closely related to
integrin recycling. For example, Rab25 contributes to tumor
progressionbydirectingthelocalizationofintegrin-recycling
vesicles and thereby enhancing the ability of tumor cells to
invade the extracellular matrix [44].International Journal of Cell Biology 3
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Figure 1: The roles of Rab GTPases involved in integrin traﬃcking. Integrins can be internalized by a clathrin-dependent, caveolin-
dependent, or clathrin- and caveolin-independent pathway. For example, some integrins are internalized by a Rab21 and clathrin-
independent pathway. Once internalized, integrins can be recycled back to the plasma membrane by a Rab4-dependent manner or can
be transported to the perinuclear recycling compartment. Rab11 family members (Rab11 and Rab25) regulate recycling of integrins from
perinuclear recycling compartment.
Table 1: Mechanisms of the internalization and recycling of integrins α5β1, α6β4, αvβ3, and αvβ6.
Integrin Internalization Recycling
Associated proteins Comments Associated proteins comments
α5β1
Numb Clathrin-dependent Rab11 Akt/GSK-3β-dependent
AP2 associated with
tetraspanin Clathrin-dependent Rab11 RCP Akt-dependent
NRP1 Clathrin-dependent VAMP3 SNARE-mediated
Rab21 Clathrin-dependent Rab21 Required for cytokinesis
? Caveolin-dependent Rab25 Promote invasion in 3D
α6β4 Rab11 Akt/GSK-3β-dependent
αvβ3 Numb
?
Clathrin-dependent
Caveolin-dependent
Rab4, PKD1
Rab4, RABIP4
Rab11
P D G F -o rV E G F - d r i v e n
PDGF-driven
Akt/GSK-3-dependent
αvβ6 HAX1 Clathrin-dependent
3. Trafﬁcking of Integrin α5β1
Integrin α5β1 is a receptor for ﬁbronectin and contributes
to cancer cell invasion, metastasis, resistance to anticancer
drugs, and decreased survival in patients [17, 45].
Integrin α5β1 is internalized by clathrin-dependent,
caveolin-dependent,andclathrin-andcaveolin-independent
mechanisms.Forclathrin-dependentendocytosis,α5β1inte-
grin binds to NUMB, an endocytic protein that inﬂu-
ences clathrin-coated pit assembly [46]. Integrin α5β1c a n
also internalize with tetraspanin protein, which interacts
with AP-2, an adaptor for clathrin-mediated endocytosis
[47]. Clathrin-dependent internalization of α5β1 integrin
with NUMB or tetraspanin has a profound eﬀect on cell
migration. In addition, α5β1 integrin can undergo Rab21-
and clathrin-independent endocytosis that is required for
successful cytokinesis [35]. In some cell types, integrin α5β1
localizes to caveolae for caveolin-mediated endocytosis [6,
48]. Caveolin-dependent endocytosis of integrin α5β1i s
critical for ﬁbronectin turnover [48].
Internalized integrin α5β1 is transported through Rab4-
positive early endosomes and arrives at the Rab11-positive
perinuclear recycling compartment [49]. Akt-mediated
glycogen synthase kinase (GSK)-3 phosphorylation is known
to deliver α5β1 from the Rab11 compartment to the
plasma membrane [50]. One of the Rab11 eﬀectors, Rab114 International Journal of Cell Biology
FIP1/RCP, associates with integrin α5β1 and regulates recy-
cling of this integrin [51]. Rab-coupling protein (RCP) pro-
vides a scaﬀold that promotes the physical association and
coordinated traﬃcking of α5β1 and epidermal growth factor
receptor 1 (EGFR1). This association drives migration of
tumor cells into three-dimensional matrices [51]. Recently,
it was shown that mutant p53 can promote invasion, loss
of directionality of migration, and metastatic behavior by
regulating the interaction of α5β1 integrin to Rab-coupling
protein, which enhances α5β1t r a ﬃcking and signaling [52].
Since Rab25 (Rab11C, Rab11 family member) binds to
Rab11 FIP1/RCP, it is hypothesized that interaction between
them may control integrin α5β1t r a ﬃcking. Recently, it has
been shown that Rab25 associates with α5β1 integrin to
enhancemigrationandinvasionofcellsinthree-dimensional
microenvironments and directs α5β1 integrin recycling to
dynamicruﬄingprotrusionsattheleadingedgeofmigrating
cells, which promotes invasive migration [29, 44]. In addi-
tion to Rab11 and Rab25, Rab21 is required for carcinoma-
associatedﬁbroblaststopromoteinvasionbycancercellsand
facilitates integrin α5β1 accumulation for force-mediated
matrix remodeling at the plasma membrane [53]. It has also
beenshownthatRab21-dependentrecyclingofintegrinα5β1
is critical for proper activation of RhoA during cytokinesis
[35].
Although most endocytosed integrin α5β1 is known to
recycle back to plasma membrane, a subset of this integrin
movestolysosomesfordegradation[37].Thisprocessisvery
slow, but it is important for α5β1-dependent cell motility
[37].
4. Trafﬁcking of Integrin α6β4
Integrin α6β4 is a receptor for laminin. Overexpression of
α6β4 integrin was seen in several types of cancers including
breast cancer and correlated with tumor invasion, increased
tumor size and grade, and a poor prognosis [54–57].
We showed that integrin α6β4 integrin recycles back to
the plasma membrane via the Rab11-positive perinuclear
recycling compartment [58]. Hypoxia stimulated carcinoma
invasion by promoting Rab11 traﬃcking of integrin α6β4,
which is dependent on hypoxia-inhibited glycogen synthase
kinase (GSK)-3 signaling [58].
5. Trafﬁcking of Integrin αvβ3
Integrin αvβ3 is a receptor for ﬁbronectin and vitronectin.
Integrin αvβ3i se x p r e s s e di nav a r i e t yo ft u m o r ss u c h
as melanoma, prostate cancer, and breast cancer [59].
Integrin αvβ3 is overexpressed in activated endothelial cells
during tumor-induced angiogenesis, whereas it is absent on
quiescent endothelial cells and normal tissues. It is known
that integrin αvβ3 promotes cancer cell survival, migration,
invasion, and metastasis [4, 60, 61].
Integrin αvβ3 is endocytosed via clathrin-dependent,
caveolin-dependent, or clathrin- and caveolin-independent
mechanisms. NUMB is an alternative clathrin adaptor and
can interact with β3 integrin, which controls αvβ3 integrin
endocytosis and cell migration [46]. In some cell types,
integrin αvβ3 is internalized by caveolin-dependent mech-
anisms [62]. In this case, MT1-MMP is clustered together
with caveolin-1 and αvβ3 integrin at motility-associated
structures, resulting in increased proteolytic activity, which
is important for cell migration and invasion [62]. A recent
study shows that upon growth factors stimulation, integrin
β3 abruptly redistributes to circular dorsal ruﬄes where it
is internalized through macropinocytosis, which plays an
important role in growth factor-induced cell migration [63].
Internalized integrin αvβ3 recycles back to the plasma
membrane via Rab4-dependent mechanisms or the Rab11-
positive perinuclear recycling compartment [23]. Following
treatment with PDGF, integrin αvβ3 was rapidly recycled
directly back to the plasma membrane from early endosomes
via a Rab4-dependent mechanism without the involvement
of Rab11 [49]. The PKC-related kinase PKD1 inﬂuences
cell migration by this fast recycling of integrin αvβ3. It is
known that PKD1 directly interacts with β3 integrin and
thisinteractionpromotesfastrecyclingofαvβ3integrinfrom
recycling endosomes to the plasma membrane upon growth
factor stimulation [64]. Activation of VEGFR1 also enhances
a Rab4A-dependent pathway that transports αvβ3-integrin
from early endosomes to the plasma membrane [65]. Recent
studies link PKD and VEGF signaling in which VEGF-A
induces recycling of integrin αvβ3i naP K D 1 - d e p e n d e n t
manner [66]. Because of the involvement of Rab4 in the
recyclingofαvβ3integrin,inhibitionofRab4eﬀectorprotein
(Rab IP4) blocks integrin recycling, leading to inhibition of
cell adhesion and cell spreading [67]. Another study suggests
that supervillin, an actin and myosin binding protein, regu-
lates rapid β3 integrin recycling through collaboration with
Rab4 and Rab5 [68]. The short-loop recycling of integrin
αvβ3 via Rab4 does not directly contribute to migration
by moving αvβ3 to the cell front, but by antagonizing
α5β1 recycling, which, in turn, inﬂuences the cell’s decision
to migrate with persistence or to move randomly [69].
Integrin αvβ3 is also recycled to the plasma membrane in a
Rab11-dependentmanner(longlooprecycling)inwhichAkt
promotes this recycling by phosphorylating and inactivating
GSK-3 [50].
6. Trafﬁcking of Integrin αvβ6
Integrin αvβ6 is a receptor for ﬁbronectin, vitronectin,
and tenascin. Integrin αvβ6 is usually expressed at low or
undetectable levels in most healthy adult epithelia but is
upregulated in many cancers such as colon cancer [70]. The
expression of integrin αvβ6 inhibits apoptosis and promotes
tumor cell invasion and metastasis, which is often associated
withamoreaggressivediseaseoutcomeandapoorprognosis
[18, 70].
Recently, the mechanism of endocytosis of integrin αvβ6
was revealed. Integrin αvβ6 is internalized by a clathrin-
dependent mechanism by interaction with HS1-associated
protein X1 (HAX1) [71]. HAX1 is found in clathrin-
coated vesicles, and the cytodomain of β6 integrin interacts
with HAX1 and is endocytosed, which increases carcinoma
migration and invasion [71].International Journal of Cell Biology 5
7. Conclusion and FutureDirection
Integrins are key regulators of cell adhesion, migration, and
proliferation.Therefore,deregulationoftheirexpressionand
altered functions play critical roles in cancer progression
by enhancing cancer cell invasion, metastasis, and survival.
There are now clear indications that integrin traﬃcking is
important to modulate integrin distribution and function.
However, more studies are needed to deﬁne the molecular
mechanisms of integrin traﬃcking in tumor progression.
M a n yq u e s t i o n sr e m a i nt ob ea n s w e r e d .O n ei m p o r t a n t
question is whether endosomal integrins can signal cell
proliferation and migration. It is known that unligated
integrins can positively or negatively regulate tumor cell
survivalandmetastasis,and,therefore,signalingarisingfrom
endosomal compartments may be important for tumor cell
survival. Another question is how traﬃcking of speciﬁc
integrins aﬀects other integrins. For instance, it has been
shown that rapid recycling of αvβ3 via the Rab4 pathway
antagonizes the Rab11-mediated α5β1 recycling, which
inﬂuences the cell’s decision to migrate with persistence
or to move randomly [69]. Because of the critical roles of
integrinsincancerprogression,integrinsarepotentialtargets
for the development of targeted anticancer therapeutics.
Understanding the mechanism of integrin traﬃcking will
provide valuable information for the development of new
anticancer drugs and clues to increase the eﬃcacy of current
anticancer therapeutics.
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